Nyxoah (STU:5YI) Operating Cash Flow per Share : €-1.21 (TTM As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nyxoah Operating Cash Flow per Share?

Nyxoah's operating cash flow per share for the three months ended in Sep. 2024 was €0.00. Nyxoah's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2024 was €-1.21.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -61.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -41.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Nyxoah's Operating Cash Flow per Share or its related term are showing as below:

STU:5YI' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -61.7 Med: -48.75 Max: 1.5
Current: -61.7

During the past 7 years, Nyxoah's highest 3-Year average Operating Cash Flow per Share Growth Rate was 1.50% per year. The lowest was -61.70% per year. And the median was -48.75% per year.

STU:5YI's 3-Year OCF Growth Rate is ranked worse than
93.87% of 685 companies
in the Medical Devices & Instruments industry
Industry Median: 3.2 vs STU:5YI: -61.70

Nyxoah Operating Cash Flow per Share Historical Data

The historical data trend for Nyxoah's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyxoah Operating Cash Flow per Share Chart

Nyxoah Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.28

-0.38

-1.07

-1.11

-1.60

Nyxoah Quarterly Data
	Jun19	Dec19	Mar20	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.37	-0.41	-0.43	-	-

Competitive Comparison of Nyxoah's Operating Cash Flow per Share

For the Medical Instruments & Supplies subindustry, Nyxoah's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nyxoah's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nyxoah's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nyxoah's Price-to-Operating-Cash-Flow falls into.

Nyxoah Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Nyxoah's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-44.778	/	27.968
	=	-1.60

Nyxoah's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2024 )	=	Cash Flow from Operations (Q: Sep. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
	=	0	/	34.381
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.21

Nyxoah Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Nyxoah's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Nyxoah Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (STU:5YI) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

NYXH:USA NYXH:Belgium

Address

Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435

Website

https://www.nyxoah.com

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Nyxoah Headlines

No Headlines